$1,000-a-day miracle drug shocks U.S. health care system
The treatment for hepatitis C is so effective that patients and doctors are clamoring for it, but heath insurers are balking at the steep costs
Hasnain says:
I'm not sure how I feel about this. On one hand, pharma needs money to fund expensive R&D to develop drugs (one estimate says the acquisition cost $11B). On the other hand, paying $90k to get rid of hep-C is a bit crazy.
Posted on 2014-04-04T16:41:43+0000